Moleculin Biotech Inc (MBRX) - Pendapatan lan volume dodolan

Moleculin Biotech Inc - logo grafis emiten MBRX

Moleculin Biotech, Inc. (MBRX) utilizes a distributed network of European and American contractors for the secure production of pharmaceuticals. The creation of unique molecules to combat brain cancer paves the way for premium pricing. The company's execution history demonstrates that the current status equals 0.00. However, the lack of stable profits and a reliance on new share issuances deprive the structure of market influence.

MBRX: Pendapatan lan volume dodolan Moleculin 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Moleculin Biotech, Inc.

- kuotasi lan prakiraan analis:
Bagan rega Moleculin Biotech, Inc.|MBRX - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar MBRX|MBRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- rincian nilai buku perusahaan:
Rega Buku Saham Moleculin Biotech|MBRX - Kapitalisasi Buku|Kapitalisasi Pasar marang Aset Bersih moleculin.com|MBRX - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Moleculin Biotech, Inc.|MBRX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal moleculin.com|MBRX - Utang perusahaan|Utang marang nilai buku Moleculin|MBRX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Moleculin Biotech|Indikator likuiditas cepet moleculin.com
- informasi bathi lan kelipatan valuasi:
MBRX - Bathi resik perusahaan|Bathi resik sing dikarepake Moleculin Biotech, Inc.|MBRX - Rasio rega marang bathi|Rega marang bathi mangsa ngarep Moleculin Biotech, Inc.|MBRX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Moleculin Biotech Inc|MBRX - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Moleculin Biotech|MBRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan moleculin.com|MBRX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Moleculin Biotech, Inc.
- statistik dodolan lan pendapatan perusahaan:
MBRX - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan moleculin.com|MBRX - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MBRX|MBRX - Wutah pendapatan YoY sajrone 12 wulan kepungkur
Analisis komprehensif perusahaan:MBRX Moleculin Biotech Inc
Produk asli Moleculin Biotech, Inc.

Moleculin Biotech, Inc. (MBRX) operates in the high-risk segment of targeted anti-tumor drug development. By analyzing the company's operating revenue dynamics, an investor can see the actual cash flow from product commercialization. This metric captures the volume of products sold, reflecting market demand and the efficiency of the current pipeline. For a biotech firm with a high concentration of resources on a single platform, growth in this indicator critically reduces binary risks.

Analisis perusahaan pesaing

Pendapatan perusahaan GERN|Pendapatan lan volume dodolan NBTX|Pendapatan lan volume dodolan Bicycle Pharma (BCYC)|CytomX Therapeutics, Inc. - Dodolan perusahaan|Total dodolan perusahaan CATX (Perspective Therapeutics Inc)|Genelux Corporation - Pendapatan lan volume dodolan|Pendapatan tahunan perusahaan MOLN|oncolyticsbiotech.com (ONCY) - Pendapatan perusahaan|Total pendapatan perusahaan Lisata (LSTA)|Pendapatan perusahaan galeratx.com|MTEM: Pendapatan dodolan perusahaan